JP2024533487A5 - - Google Patents
Info
- Publication number
- JP2024533487A5 JP2024533487A5 JP2024516396A JP2024516396A JP2024533487A5 JP 2024533487 A5 JP2024533487 A5 JP 2024533487A5 JP 2024516396 A JP2024516396 A JP 2024516396A JP 2024516396 A JP2024516396 A JP 2024516396A JP 2024533487 A5 JP2024533487 A5 JP 2024533487A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- fusion polypeptide
- ferritin
- self
- fusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163243402P | 2021-09-13 | 2021-09-13 | |
| US63/243,402 | 2021-09-13 | ||
| PCT/CA2022/051360 WO2023035083A1 (en) | 2021-09-13 | 2022-09-13 | Optimized multabody constructs, compositions, and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024533487A JP2024533487A (ja) | 2024-09-12 |
| JP2024533487A5 true JP2024533487A5 (cg-RX-API-DMAC10.html) | 2025-09-24 |
Family
ID=85506121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516396A Pending JP2024533487A (ja) | 2021-09-13 | 2022-09-13 | 最適化されたＭｕｌｔａｂｏｄｙ構築物、組成物、及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240400704A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4402179A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024533487A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240102943A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118488971A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022343032A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3231173A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MX2024003140A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023035083A1 (cg-RX-API-DMAC10.html) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR103268A1 (es) * | 2014-12-23 | 2017-04-26 | Bristol Myers Squibb Co | Anticuerpos contra tigit |
| CA3143034A1 (en) * | 2019-06-14 | 2020-12-17 | Cugene Inc. | Novel interleukin-2 variants for the treatment of cancer |
| CA3149320A1 (en) * | 2019-08-01 | 2021-02-04 | The Hospital For Sick Children | Multi-valent and multi-specific nanoparticle platforms and methods |
| TW202600603A (zh) * | 2019-10-24 | 2026-01-01 | 美商普羅米修斯生物科學股份有限公司 | 針對類-tnf配體1a (tl1a)之人類化抗體及其用途 |
| CN115768794A (zh) * | 2020-02-24 | 2023-03-07 | 艾利妥 | 抗trem2抗体的使用方法 |
| CN117157328A (zh) * | 2021-01-28 | 2023-12-01 | 儿童医院 | Multabody构建体、组合物和方法 |
-
2022
- 2022-09-13 MX MX2024003140A patent/MX2024003140A/es unknown
- 2022-09-13 JP JP2024516396A patent/JP2024533487A/ja active Pending
- 2022-09-13 KR KR1020247011820A patent/KR20240102943A/ko active Pending
- 2022-09-13 WO PCT/CA2022/051360 patent/WO2023035083A1/en not_active Ceased
- 2022-09-13 US US18/691,267 patent/US20240400704A1/en active Pending
- 2022-09-13 CN CN202280066146.9A patent/CN118488971A/zh active Pending
- 2022-09-13 EP EP22865992.6A patent/EP4402179A4/en active Pending
- 2022-09-13 CA CA3231173A patent/CA3231173A1/en active Pending
- 2022-09-13 AU AU2022343032A patent/AU2022343032A1/en active Pending